Ocugen Misses Q2 EPS by 1c
- ByInvesting.com-
Ocugen (NASDAQ:OCGN) reported Q2 EPS of ($0.09), $0.01 worse than the analyst estimate of ($0.08).
Symbol | Exchange | Currency |
---|
Ocugen (NASDAQ:OCGN) reported Q2 EPS of ($0.09), $0.01 worse than the analyst estimate of ($0.08).
Pre-Open Stock Movers:VMware (NYSE:VMW) 20% HIGHER; Broadcom (NASDAQ:AVGO) is in advanced talks to acquire VMware (VMW), according to various media sources.SIGA Technologies,...
By Sam BougheddaInvesting.com -- Ocugen, Inc. (NASDAQ:OCGN) dropped Friday after it announced the FDA declined to issue Emergency Use Authorization (EUA) approval for Covaxin,...
Ocugen, Inc. is a biopharmaceutical company focused on developing gene therapies to cure blindness diseases and developing vaccine for COVID-19. The Company's technology pipeline includes: COVID-19 Vaccine (0.5), Modifier Gene Therapy Platform and Novel Biologic Therapies for Retinal Diseases. COVID-19 Vaccine candidate is focused on developing, manufacturing and commercializing COVAXIN for the prevention of COVID-19 in humans in the Ocugen Covaxin Territory. COVAXIN is a whole-virion inactivated COVID-19 vaccine candidate and is formulated with the inactivated SARS-CoV-2 virus. The Modifier Gene Therapy platform is designed for retinal diseases, including retinitis pigmentosa (RP), leber congenital amaurosis (LCA) and dry age-related macular degeneration (AMD). It is developing OCU200, a biologic product candidate to treat diabetic macular edema (DME), diabetic retinopathy (DR) and wet AMD. OCU400, its first product candidate being developed with its modifier gene therapy platform.
Type | 5 Min | 15 Min | Hourly | Daily | Monthly |
---|---|---|---|---|---|
Moving Averages | Sell | Sell | Sell | Strong Sell | Sell |
Technical Indicators | Sell | Strong Buy | Strong Sell | Strong Sell | Strong Sell |
Summary | Sell | Neutral | Strong Sell | Strong Sell | Strong Sell |
Name | Last | High | Low | Chg. | Chg. % | Vol. | Time | ||
---|---|---|---|---|---|---|---|---|---|
450.10 | 453.80 | 429.20 | +2.40 | +0.54% | 608.40K | London | |||
595.40 | 601.60 | 586.60 | +2.40 | +0.41% | 5.77M | London | |||
1,969.50 | 1,970.50 | 1,938.50 | +27.50 | +1.42% | 1.45M | London | |||
589.50 | 591.50 | 581.50 | -2.50 | -0.42% | 614.93K | London | |||
162.30 | 162.30 | 160.50 | +1.10 | +0.68% | 2.42M | London | |||
3,160.00 | 3,189.00 | 3,154.00 | -3.0 | -0.10% | 644.45K | London | |||
1,167.50 | 1,175.00 | 1,165.50 | +2.50 | +0.21% | 4.47M | London | |||
338.50 | 342.00 | 337.50 | -3.00 | -0.88% | 470.56K | London | |||
161.85 | 162.30 | 157.90 | -4.15 | -2.50% | 5.83M | London | |||
498.25 | 498.25 | 484.30 | +11.55 | +2.37% | 37.25M | London | |||
540.70 | 543.10 | 532.00 | -4.40 | -0.81% | 33.49M | London | |||
121.56 | 122.06 | 120.74 | -0.22 | -0.18% | 76.31M | London | |||
2,418.00 | 2,418.00 | 2,372.50 | +29.00 | +1.21% | 1.98M | London | |||
4,592.00 | 4,681.00 | 4,570.00 | -35.0 | -0.76% | 415.77K | London | |||
52.50 | 52.50 | 52.50 | +7.000 | +15.38% | 1.00M | London |